Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., trading under the ticker HSAQ, is a blank-check company that completed its initial public offering in 2021 with a focus on the healthcare and medical device sector, specifically targeting companies in bioelectronic medicine and cardiovascular therapeutics. The company filed a Form 10-Q with the SEC on August 16, 2021, reflecting its status as an active special purpose acquisition company in the search phase following its IPO. Orchestra BioMed's underlying business centers on developing implantable bioelectronic therapies for cardiovascular disease, representing a specialized niche within the broader life sciences and medtech deal landscape. Visit SpacDesk and sign up for full access to HSAQ filings, deal timelines, and comparable SPAC transaction data.